Pushpa Tandon received her M.Sc. and Ph.D. degrees in biochemistry from the University of Lucknow, India. She came to the US as a Fogarty Fellow, and continued her research at the U.S. Environmental Protection Agency, Boston College, and then at Harvard Medical School before moving to Wellstat Therapeutics, in Maryland. She joined NIH as a Scientific Review Officer in the Center for Scientific Review. She is currently a Program Director in the Cancer Imaging Program, in the Division of Cancer Therapeutics and Diagnosis at NCI.
JTEHM, Articles, Published ArticlesThe National Institutes of Health Affordable Cancer Technologies Program: Improving Access to Resource-Appropriate Technologies for Cancer Detection, Diagnosis, Monitoring and Treatment in Low- and Middle-Income Countries
Paul C. Pearlman, Rao Divi, Michael Gwede, Pushpa Tandon, Brian S. Sorg, Miguel R. Ossandon, Lokesh Agrawal, Vinay Pai, Houston Baker, Tiffani Bailey Lash
This Article is Featured in the Special Issue NIH-IEEE POCT 2015 Point-of-care (POC) technologies have proved valuable in cancer detection, diagnosis, monitoring, and treatment in the developed world, and have shown promise in low-and-middle-income countries (LMIC) as well. Despite this promise,... Read more
Posted on 12 SEP 2016
JTEHM, Articles, Published ArticlesThe Role of Affordable, Point-of-Care Technologies for Cancer Care in Low-and Middle-Income Countries: A Review & Commentary
As the burden of non-communicable diseases such as cancer continues to rise in low- and middle-income countries (LMICs), it is essential to identify and invest in promising solutions for cancer control and treatment. Point-of-care technologies (POCTs) have played critical roles... Read more
Posted on 14 NOV 2017